Investor Fact Sheet

Name:
Island Pharmaceuticals Limited

Business Description:
Island Pharmaceuticals is mid clinical-stage drug repurposing company, focused on the newsworthy area of antiviral therapeutics for infectious diseases.

Established:
Island Pharmaceuticals Limited (ILA) was listed on the Australian Stock Exchange on 13 April 2021
Island Pharmaceuticals was incorporated on 25 May 2020.

Shares on Issue:
80,968,468 ordinary shares

Listings:
Australian Securities Exchange (ASX code: ILA)

Registered Office:
Suite 201, 697 Burke Road
Camberwell, Victoria 3124

Principal Place of Business:
Suite 201
697 Burke Road
Camberwell, Victoria 3124
Telephone:
Email: info@islandpharmaceuticals.com

Managing Director:
Dr David Foster

Company Secretary:
Mr Peter Webse

Directors
Dr. Paul MacLeman - Executive Chairman
Dr. David Foster - Managing Director - CEO
Dr. David Brookes - Non Executive Director
Mr. Albert Hansen - Non Executive Director
Dr. Anna Lavelle - Non Executive Director

Chief Financial Officer
Mr Cameron Jones

Auditor:
Grant Thornton

Share Registry:
Automic Registry Services
Level 5, 126 Phillip Street, Sydney, Nsw, Australia, 2000
Telephone:
1300 288 664 (within Australia)
+61 2 9698 5414 (outside Australia)
Facsimile: +61 2 8583 3040